Sunrise Partners Limited Partnership »

Lyell Immunopharma shares owned by Sunrise Partners Limited Partnership

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Sunrise Partners Limited Partnership from 13F filings

Historical chart of Sunrise Partners Limited Partnership investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Sunrise Partners Limited Partnership consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Sunrise Partners Limited Partnership

Quarter filed Position value Share count Share price at filing
2024-09-30 $23k 17k 1.38

More positions owned by Sunrise Partners Limited Partnership

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Alcoa Call Option (AA)
ConocoPhillips (COP)
Teck Resources CL B Call Option (TECK)
Intel Corporation (INTC)
Aptiv Com Shs
Wolfspeed Note 1.750% 5/0 (Principal)
Nio Note 4.625%10/1 (Principal)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Allegro Microsystems Ord (ALGM)
EQT Corporation (EQT)
Ssr Mining In Note 2.500% 4/0 (Principal)
Darling International (DAR)
Zto Express Cayman Note 1.500% 9/0 (Principal)
Draftkings Com Cl A Call Option (DKNG)

View all positions for Sunrise Partners Limited Partnership

Top funds holding Lyell Immunopharma

MWG Management
Orland Properties
BlackRock
Vanguard Group
Foresite Capital Management IV
WuXi AppTec
venBio Partners
T. Rowe Price Associates
Alphabet
Geode Capital Management
Citadel Advisors
State Street Corporation
OrbiMed Advisors
Sc China Holding
MIC Capital Management UK

View all funds holding Lyell Immunopharma